Literature DB >> 25400735

Expression of annexin A7 and its clinical significance in differentiation and metastasis of gastric carcinoma.

Hu-Fang Yuan1, Yong Li1, Qun Zhao1, Li-Qiao Fan1, Bi-Bo Tan1, Wei-Hua Ye1.   

Abstract

OBJECTIVE: To investigate the expression and clinical significance of annexin A7 in the differentiation and lymphatic metastasis of gastric cancer (GC).
METHODS: The clinical and pathological data were recorded for analysis. Immunohistochemical staining and Western blot were performed to analyze the expression of ANXA 7 in primary GC tissues. Logistic regression analyses were conducted to evaluate the associations between annexin A7 expression levels and differentiations of GC. Analyses of the ROC were conducted to determine the cut-off value of the ratio of pixel density of annexin A7 for predicting lymphatic metastasis of GC.
RESULTS: A total of 162 GC patients were enrolled in this study, and expression rate of annexin A7 was 65.4% in GC. The survival rate of patients with positive expression of annexin A7 was lower than that in patients with negative expression (P=0.000). The results of COX regression showed that the positive expression of annexin A7, submucosal confinement and pathological stage of GC were associated with poor clinical outcomes. The ratio of pixel density value of primary GC tissues with PN 1-3 lymphatic spread was significantly higher than those in tissues with PN 0 lymphatic spread (0.56±0.09 vs. 0.42±0.07, P < 0.05). ROC analysis showed a high area under the curve for the ratio of pixel density value of annexin A7 in primary GC tissues. At a cut-off level of > 0.505, the ratio of pixel density value of annexin A7 exhibited 76.7% sensitivity and 88.3% specificity for detecting lymphatic metastasis of GC.
CONCLUSION: High annexin A7 expression is associated with poor differentiation in GC patients, and it may be a predictor for lymphatic metastasis of GC.

Entities:  

Keywords:  Annexin A7; cancer differentiation; gastric cancer; lymphatic metastasis; predictor

Mesh:

Substances:

Year:  2014        PMID: 25400735      PMCID: PMC4230099     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  15 in total

1.  Annexin A7 trafficking to alveolar type II cell surface: possible roles for protein insertion into membranes and lamellar body secretion.

Authors:  Avinash Chander; Tudevdagva Gerelsaikhan; Pavan K Vasa; Kelly Holbrook
Journal:  Biochim Biophys Acta       Date:  2013-02-19

2.  Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity.

Authors:  Dongyun Yang; Andrew Hendifar; Cosima Lenz; Kayo Togawa; Felicitas Lenz; Georg Lurje; Alexandra Pohl; Thomas Winder; Yan Ning; Susan Groshen; Heinz-Josef Lenz
Journal:  J Gastrointest Oncol       Date:  2011-06

3.  Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.

Authors:  Yelizaveta Torosyan; Albert Dobi; Shanmugam Naga; Katerina Mezhevaya; Mirta Glasman; Christine Norris; Guisen Jiang; Gregory Mueller; Harvey Pollard; Meera Srivastava
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

4.  The Anx7(+/-) knockout mutation alters electrical and secretory responses to Ca(2+)-mobilizing agents in pancreatic β-cells.

Authors:  David Mears; Charles L Zimliki; Illani Atwater; Eduardo Rojas; Mirta Glassman; Ximena Leighton; Harvey B Pollard; Meera Srivastava
Journal:  Cell Physiol Biochem       Date:  2012-05-11

Review 5.  Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.

Authors:  Connie R Jimenez; Jaco C Knol; Gerrit A Meijer; Remond J A Fijneman
Journal:  J Proteomics       Date:  2010-06-23       Impact factor: 4.044

6.  Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients.

Authors:  Meera Srivastava; Lukas Bubendorf; Mark Raffeld; Christoph Bucher; Jochen Torhorst; Guido Sauter; Cara Olsen; Olli P Kallioniemi; Ofer Eidelman; Harvey B Pollard
Journal:  Clin Cancer Res       Date:  2004-04-01       Impact factor: 12.531

7.  The significance of ANXA7 expression and its correlation with poor cellular differentiation and enhanced metastatic potential of gastric cancer.

Authors:  Ping-I Hsu; Ming-Shyan Huang; Hui-Chun Chen; Ping-Ning Hsu; Tsung-Ching Lai; Jui-Ling Wang; Gin-Ho Lo; Kwok-Hung Lai; Ching-Jiunn Tseng; Michael Hsiao
Journal:  J Surg Oncol       Date:  2008-06-01       Impact factor: 3.454

Review 8.  Potential role of annexin A7 in cancers.

Authors:  Chunmei Guo; Shuqing Liu; Frederick Greenaway; Ming-Zhong Sun
Journal:  Clin Chim Acta       Date:  2013-04-29       Impact factor: 3.786

9.  BART inhibits pancreatic cancer cell invasion by PKCα inactivation through binding to ANX7.

Authors:  Keisuke Taniuchi; Kunihiko Yokotani; Toshiji Saibara
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

Review 10.  ANX7 as a bio-marker in prostate and breast cancer progression.

Authors:  M Srivastava; L Bubendorf; L Nolan; M Glasman; X Leighton; G Miller; W Fehrle; M Raffeld; O Eidelman; O P Kallioniemi; S Srivastava; H B Pollard
Journal:  Dis Markers       Date:  2001       Impact factor: 3.434

View more
  3 in total

Review 1.  What gastric cancer proteomic studies show about gastric carcinogenesis?

Authors:  Mariana Ferreira Leal; Fernanda Wisnieski; Carolina de Oliveira Gigek; Leonardo Caires do Santos; Danielle Queiroz Calcagno; Rommel Rodriguez Burbano; Marilia Cardoso Smith
Journal:  Tumour Biol       Date:  2016-04-28

2.  Annexin A7 expression is downregulated in late-stage gastric cancer and is negatively correlated with the differentiation grade and apoptosis rate.

Authors:  Weihua Ye; Yong Li; Liqiao Fan; Qun Zhao; Hufang Yuan; Bibo Tan; Zhidong Zhang
Journal:  Oncol Lett       Date:  2018-04-25       Impact factor: 2.967

Review 3.  Pathobiological functions and clinical implications of annexin dysregulation in human cancers.

Authors:  Llara Prieto-Fernández; Sofía T Menéndez; María Otero-Rosales; Irene Montoro-Jiménez; Francisco Hermida-Prado; Juana M García-Pedrero; Saúl Álvarez-Teijeiro
Journal:  Front Cell Dev Biol       Date:  2022-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.